Impact of Bevel Orientation on Arteriovenous Fistula Puncture in Hemodialysis
Recruiting
N/A
Interventional Study
End-Stage Renal Disease Requiring Haemodialysis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 240 (estimated)
- Sponsor
- Centre Hospitalier Emile Roux · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
End-stage renal disease (ESRD) is a condition in which the filtration function of the kidneys has deteriorated, necessitating dialysis or transplantation. With an aging population, the number of patients undergoing dialysis for CKD is constantly increasing.
There are different types of dialysis treatment: hemodialysis and peritoneal dialysis.
Hemodialysis involves exchanges between blood and a d…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* male or female with Chronic Kidney Disease
* patient requiring 4-hour hemodialysis sessions, 3 times per week, in a dialysis center
* Native arteriovenous fistula (AVF) (without prosthesis), mature, with no prior puncture, located in the upper limb
* First fistula for a hemodi…
Contacts